Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Related structures:
AlphaFold database: A4IBJ3
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 12 |
GO:0006396 | RNA processing | 6 | 12 |
GO:0006397 | mRNA processing | 7 | 12 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 12 |
GO:0006807 | nitrogen compound metabolic process | 2 | 12 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0009987 | cellular process | 1 | 12 |
GO:0016070 | RNA metabolic process | 5 | 12 |
GO:0016071 | mRNA metabolic process | 6 | 12 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 12 |
GO:0043170 | macromolecule metabolic process | 3 | 12 |
GO:0044237 | cellular metabolic process | 2 | 12 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0046483 | heterocycle metabolic process | 3 | 12 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:0090304 | nucleic acid metabolic process | 4 | 12 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 12 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 12 |
GO:0003824 | catalytic activity | 1 | 12 |
GO:0004842 | ubiquitin-protein transferase activity | 4 | 12 |
GO:0005488 | binding | 1 | 12 |
GO:0008270 | zinc ion binding | 6 | 12 |
GO:0016740 | transferase activity | 2 | 12 |
GO:0019787 | ubiquitin-like protein transferase activity | 3 | 12 |
GO:0043167 | ion binding | 2 | 12 |
GO:0043169 | cation binding | 3 | 12 |
GO:0046872 | metal ion binding | 4 | 12 |
GO:0046914 | transition metal ion binding | 5 | 12 |
GO:0061630 | ubiquitin protein ligase activity | 5 | 12 |
GO:0061659 | ubiquitin-like protein ligase activity | 4 | 12 |
GO:0097159 | organic cyclic compound binding | 2 | 12 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 12 |
GO:1901363 | heterocyclic compound binding | 2 | 12 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 26 | 30 | PF00656 | 0.442 |
CLV_C14_Caspase3-7 | 92 | 96 | PF00656 | 0.578 |
CLV_NRD_NRD_1 | 142 | 144 | PF00675 | 0.712 |
CLV_NRD_NRD_1 | 254 | 256 | PF00675 | 0.468 |
CLV_NRD_NRD_1 | 399 | 401 | PF00675 | 0.479 |
CLV_PCSK_FUR_1 | 140 | 144 | PF00082 | 0.605 |
CLV_PCSK_KEX2_1 | 142 | 144 | PF00082 | 0.712 |
CLV_PCSK_KEX2_1 | 253 | 255 | PF00082 | 0.464 |
CLV_PCSK_KEX2_1 | 401 | 403 | PF00082 | 0.442 |
CLV_PCSK_PC1ET2_1 | 253 | 255 | PF00082 | 0.421 |
CLV_PCSK_PC1ET2_1 | 401 | 403 | PF00082 | 0.442 |
CLV_PCSK_PC7_1 | 250 | 256 | PF00082 | 0.439 |
CLV_PCSK_SKI1_1 | 216 | 220 | PF00082 | 0.496 |
CLV_PCSK_SKI1_1 | 243 | 247 | PF00082 | 0.422 |
CLV_PCSK_SKI1_1 | 250 | 254 | PF00082 | 0.449 |
CLV_PCSK_SKI1_1 | 394 | 398 | PF00082 | 0.649 |
CLV_PCSK_SKI1_1 | 78 | 82 | PF00082 | 0.708 |
DEG_APCC_DBOX_1 | 83 | 91 | PF00400 | 0.485 |
DEG_SPOP_SBC_1 | 89 | 93 | PF00917 | 0.475 |
DOC_CYCLIN_RxL_1 | 390 | 399 | PF00134 | 0.630 |
DOC_CYCLIN_yCln2_LP_2 | 221 | 227 | PF00134 | 0.537 |
DOC_MAPK_gen_1 | 213 | 223 | PF00069 | 0.476 |
DOC_PP1_RVXF_1 | 217 | 224 | PF00149 | 0.583 |
DOC_PP2B_LxvP_1 | 38 | 41 | PF13499 | 0.537 |
DOC_PP4_FxxP_1 | 103 | 106 | PF00568 | 0.545 |
DOC_PP4_FxxP_1 | 187 | 190 | PF00568 | 0.468 |
DOC_USP7_MATH_1 | 307 | 311 | PF00917 | 0.729 |
DOC_USP7_MATH_1 | 89 | 93 | PF00917 | 0.723 |
DOC_USP7_MATH_1 | 98 | 102 | PF00917 | 0.636 |
DOC_WW_Pin1_4 | 308 | 313 | PF00397 | 0.728 |
LIG_14-3-3_CanoR_1 | 72 | 80 | PF00244 | 0.582 |
LIG_14-3-3_CanoR_1 | 8 | 15 | PF00244 | 0.430 |
LIG_BRCT_BRCA1_1 | 137 | 141 | PF00533 | 0.565 |
LIG_BRCT_BRCA1_1 | 164 | 168 | PF00533 | 0.563 |
LIG_BRCT_BRCA1_1 | 3 | 7 | PF00533 | 0.456 |
LIG_BRCT_BRCA1_1 | 99 | 103 | PF00533 | 0.587 |
LIG_FHA_1 | 356 | 362 | PF00498 | 0.661 |
LIG_FHA_1 | 4 | 10 | PF00498 | 0.353 |
LIG_FHA_1 | 51 | 57 | PF00498 | 0.593 |
LIG_FHA_2 | 114 | 120 | PF00498 | 0.454 |
LIG_FHA_2 | 130 | 136 | PF00498 | 0.463 |
LIG_FHA_2 | 234 | 240 | PF00498 | 0.456 |
LIG_FHA_2 | 275 | 281 | PF00498 | 0.598 |
LIG_FHA_2 | 303 | 309 | PF00498 | 0.774 |
LIG_Integrin_RGD_1 | 175 | 177 | PF01839 | 0.651 |
LIG_LIR_Apic_2 | 100 | 106 | PF02991 | 0.540 |
LIG_LIR_Apic_2 | 184 | 190 | PF02991 | 0.503 |
LIG_LIR_Gen_1 | 259 | 269 | PF02991 | 0.625 |
LIG_LIR_Nem_3 | 259 | 264 | PF02991 | 0.472 |
LIG_MYND_1 | 85 | 89 | PF01753 | 0.482 |
LIG_SH2_NCK_1 | 65 | 69 | PF00017 | 0.418 |
LIG_SH2_STAT5 | 194 | 197 | PF00017 | 0.266 |
LIG_SH3_3 | 222 | 228 | PF00018 | 0.530 |
LIG_SH3_3 | 309 | 315 | PF00018 | 0.482 |
LIG_SH3_3 | 366 | 372 | PF00018 | 0.561 |
LIG_SH3_3 | 82 | 88 | PF00018 | 0.584 |
LIG_TRAF2_1 | 116 | 119 | PF00917 | 0.447 |
LIG_TRAF2_1 | 386 | 389 | PF00917 | 0.429 |
LIG_TRAF2_1 | 41 | 44 | PF00917 | 0.427 |
MOD_CDC14_SPxK_1 | 311 | 314 | PF00782 | 0.477 |
MOD_CDK_SPxK_1 | 308 | 314 | PF00069 | 0.494 |
MOD_CK1_1 | 23 | 29 | PF00069 | 0.549 |
MOD_CK1_1 | 259 | 265 | PF00069 | 0.517 |
MOD_CK1_1 | 274 | 280 | PF00069 | 0.525 |
MOD_CK1_1 | 303 | 309 | PF00069 | 0.677 |
MOD_CK1_1 | 310 | 316 | PF00069 | 0.632 |
MOD_CK1_1 | 93 | 99 | PF00069 | 0.593 |
MOD_CK2_1 | 113 | 119 | PF00069 | 0.469 |
MOD_CK2_1 | 302 | 308 | PF00069 | 0.757 |
MOD_GlcNHglycan | 100 | 103 | PF01048 | 0.608 |
MOD_GlcNHglycan | 210 | 213 | PF01048 | 0.599 |
MOD_GlcNHglycan | 273 | 276 | PF01048 | 0.729 |
MOD_GlcNHglycan | 300 | 303 | PF01048 | 0.636 |
MOD_GlcNHglycan | 75 | 78 | PF01048 | 0.545 |
MOD_GSK3_1 | 298 | 305 | PF00069 | 0.674 |
MOD_GSK3_1 | 89 | 96 | PF00069 | 0.570 |
MOD_N-GLC_1 | 291 | 296 | PF02516 | 0.722 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.381 |
MOD_NEK2_1 | 20 | 25 | PF00069 | 0.374 |
MOD_NEK2_1 | 355 | 360 | PF00069 | 0.537 |
MOD_NEK2_1 | 49 | 54 | PF00069 | 0.583 |
MOD_NEK2_1 | 80 | 85 | PF00069 | 0.712 |
MOD_NEK2_1 | 9 | 14 | PF00069 | 0.409 |
MOD_NEK2_2 | 3 | 8 | PF00069 | 0.361 |
MOD_PKA_2 | 71 | 77 | PF00069 | 0.592 |
MOD_Plk_1 | 233 | 239 | PF00069 | 0.446 |
MOD_Plk_2-3 | 357 | 363 | PF00069 | 0.650 |
MOD_Plk_4 | 20 | 26 | PF00069 | 0.568 |
MOD_Plk_4 | 227 | 233 | PF00069 | 0.400 |
MOD_Plk_4 | 256 | 262 | PF00069 | 0.571 |
MOD_ProDKin_1 | 308 | 314 | PF00069 | 0.719 |
TRG_DiLeu_BaEn_3 | 43 | 49 | PF01217 | 0.410 |
TRG_DiLeu_BaLyEn_6 | 374 | 379 | PF01217 | 0.509 |
TRG_ENDOCYTIC_2 | 65 | 68 | PF00928 | 0.403 |
TRG_ER_diArg_1 | 141 | 143 | PF00400 | 0.568 |
TRG_ER_diArg_1 | 254 | 256 | PF00400 | 0.456 |
TRG_ER_diArg_1 | 84 | 87 | PF00400 | 0.643 |
TRG_Pf-PMV_PEXEL_1 | 359 | 363 | PF00026 | 0.732 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IJT3 | Leptomonas seymouri | 67% | 97% |
A0A0S4JGE6 | Bodo saltans | 32% | 100% |
A0A1X0P6U9 | Trypanosomatidae | 44% | 100% |
A0A3Q8IMI0 | Leishmania donovani | 100% | 100% |
A0A3S5ISL5 | Trypanosoma rangeli | 44% | 100% |
A4HMX2 | Leishmania braziliensis | 84% | 100% |
C9ZZ48 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 45% | 100% |
E9AFC9 | Leishmania major | 92% | 100% |
E9B6I4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |
V5DUR5 | Trypanosoma cruzi | 43% | 100% |